European Hematology Association
Westblaak 71
Rotterdam
3012 KE
Tel: 31-10-404-56-21
Fax: 31-10-436-18-17
Website: http://www.ecah.org/
Email: cme@ehaweb.org
176 articles with European Hematology Association
-
Tolero Pharmaceuticals to Highlight Clinical Data Evaluating Investigational Agent Alvocidib in Patients with Newly Diagnosed AML at EHA 2019
5/16/2019
Tolero Pharmaceuticals, Inc. announced that new data from two abstracts on the Company's investigational pipeline will be presented at the 24th Congress of the European Hematology Association, taking place June 13-16, 2019 in Amsterdam, The Netherlands.
-
Oncopeptides Announces Acceptance of Four Abstracts Highlighting Melflufen Clinical Programs for Presentation at 24th EHA Congress in June 2019
5/16/2019
Oncopeptides AB announced that a total of four abstracts have been accepted for presentation at the 24th Congress of European Hematology Association meeting.
-
Sutro Biopharma Announces Presentation at the 2019 European Hematology Association Congress
5/16/2019
Sutro Biopharma, Inc. announced that the company will present at the upcoming European Hematology Association Congress being held June 13-16, 2019, in Amsterdam.
-
Basel, Switzerland-based Novartis announced that between the ASCO meeting and the 23rd Annual Congress of the European Hematology Association (EHA) meeting being held June 14 to 17 in Stockholm, Sweden, it will be presenting 84 abstracts.
-
Verastem Reports Phase II Long-Term Follow-Up Data For Duvelisib In Patients With Double-Refractory Follicular Lymphoma And Small Lymphocytic Lymphoma At The 22nd Congress Of The European Hematology Association
6/26/2017
-
TG Therapeutics Recaps Data From Triple Combination Therapy Trials At The 22nd European Hematology Association Annual Congress
6/26/2017
-
Ra Pharma Presents Data On Oral Small Molecule Complement Inhibitors At The 22nd Congress Of European Hematology Association
6/26/2017
-
Onconova Presents Rigosertib Data At The 22nd Congress Of The European Hematology Association In Madrid
6/26/2017
-
European Hematology Association: Multicenter Open-Label Phase 2 Study Of Ibrutinib In Chronic Graft Versus Host Disease (cGVHD) After Failure Of Corticosteroids
6/26/2017
-
European Hematology Association: Global Trial Of The Efficacy And Safety Of CTL019 In Adult Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma: An Interim Analysis Of The JULIET Study
6/26/2017
-
European Hematology Association: Early Metabolic Response Determination By FDG-PET Allows Substantial Reduction Of Chemotherapy And Its Toxicity In Patients With Advanced Stage Hodgkin Lymphoma: The GHSG HD18 Study
6/26/2017
-
European Hematology Association: Clinical And Biologic Covariates Of Outcomes In ZUMA-1: A Pivotal Trial Of Axicabtagene Ciloleucel (Axi-Cel; KTE-C19) In Patients With Refractory Aggressive Non-Hodgkin Lymphoma (NHL)
6/26/2017
-
European Hematology Association: Bleeding Or Clotting In Elderly Patients With Cancer-Associated Venous Thromboembolism: Which Is Worse?
6/26/2017
-
AOP Orphan Pharmaceuticals AG And PharmaEssentiaAnnounce Latest Clinical Results For Ropeginterferon Alfa-2b In Polycythemia Vera From 3 Abstracts Presented At The 22nd Congress Of The European Hematology Association In Madrid
6/26/2017
-
Sunesis Announces Presentation Of Updated Results From Washington University-Sponsored Phase I/Cohort Expansion Trial Of Vosaroxin Plus Azacitidine In Patients With MDS At The European Hematology Association Annual Meeting
6/23/2017
-
Stemline Presents SL-401 Updated Stage 1 And 2 Data From Ongoing Pivotal Trial In BPDCN And Safety Experience Across Multiple Indications, Today At European Hematology Association
6/23/2017
-
Positive Phase Ib Data For NewLink Genetics’ IDO Pathway Inhibitor, Indoximod, In Combination With Chemotherapy For Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) Presented At The European Hematology Association Congress In Madrid, Spain
6/23/2017
-
Karyopharm Reports Updated Phase IIb SADAL Data For Selinexor In Diffuse Large B-Cell Lymphoma At The 2017 European Hematology Association Annual Meeting
6/23/2017
-
European Hematology Association: Two Is Better Than One: The Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Rapid Tumor Responses In A Phase II Study For Relapsed/Refractory NHL
6/23/2017
-
European Hematology Association: Treating Sickle Cell Disease And Beta-Thalassemia With CRISPR/Cas9 Gene Editing
6/23/2017